Showing 661-670 of 8927 results for "".
The Time is Now: Dermatology and Climate Change
https://practicaldermatology.com/topics/practice-management/the-time-is-now-dermatology-and-climate-change/19930/How are global warming and associated changes in weather affecting the presentation of skin diseases? And what opportunities do dermatologists have to help turn the tide of global warning? Misha Rosenbach, MD reviews the science and touches on opportunities for change.Scientifically Speaking: Can We Conquer Cellulite?
https://practicaldermatology.com/series/scientifically-speaking/scientifically-speaking-can-we-conquer-cellulite/19872/Treating cellulite has been a challenge, but new and emerging technologies offer hope to overcome this common condition. Host Joel L. Cohen, MD talks with Nazanin Saedi, MD, Endo's Mike McLane, PhD, and Soliton's Wally Klemp.Conversations in Acne, Part 1
https://practicaldermatology.com/topics/acne-rosacea/conversations-in-acne-part-1/19867/As treatment options for acne expand, clinicians consider the potential to combine topical therapies or pair topicals with systemics, all while adhering to guidelines for care and prescribing antibiotics responsibly. In the first episode of this three-part series, host Neal Bhatia, MD speaks with HiCrisis Management: Office Operations, Part 2
https://practicaldermatology.com/topics/practice-management/crisis-management-office-operations-part-2/18182/Practice shut downs for COVID-19 will have long-term consequences for medical aesthetic practices. Deirdre Hooper, MD, Ashish Bhatia, MD, Kevin Pinski, MD, and Nancy Samolitis, MD share their predictions with host Neal Bhatia, MD.Anatomy Lesson: Targeting the Underlying Cause of Wrinkles with Injections
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/anatomy-lesson-targeting-the-underlying-cause-of-wrinkles-with-injections/19778/Patients need to understand that addressing the underlying causes of wrinkles and folds such as changes in bony structures with injectables will provide a more natural result than simply chasing wrinkles and folds, says Jeanette M. Black, MD.Check Mate: Ensuring Quality
https://practicaldermatology.com/topics/practice-management/check-mate-ensuring-quality/19677/To ensure consistency of care and that patients are properly prepped and cleared for treatment, Doris Day, MD has implemented checklists. She explains how the lists have improved staff management.Bristol-Myers Squibb Acquires Celgene, My UV Tracker, More
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-bristol-myers-squibb-acquires-celgene-my-skin-track-uv-more/19534/Bristol-Myers Squibb will acquire Celgene in a cash and stock transaction with an equity value of approximately $74 Billion. Suneva® Medical partners with Healeon Medical, Inc. and Puregraft, LLC to add two new products to its aesthetics portfolio. Unveiled at the 2018 Consumer Electronics Show, theUpdates from CSF, PsA Guidelines, Revance Data
https://practicaldermatology.com/series/dermwire-tv/dermwire-tv-updates-from-csf-psa-guidelines-revance-data/18200/Cosmetic Surgery Forum celebrates a decade of success. The meeting, featuring a panel of experts in both medical and cosmetic dermatology, wrapped up on Saturday and is already announcing plans for 2019. When it comes to psoriatic arthritis, prescribers should treat to target, new guidelines from thDupixent for Adolescents priority review, Restylane Lyft via cannulas, Hyperhidrosis Awareness
https://practicaldermatology.com/series/dermwire-tv/dermwire-tv-dupixent-for-adolescents-priority-review-restylane-lyft-via-cannulas-hyperhidrosis-awareness/18215/FDA grants priority review for Sanofi's and Regeneron's sBLA for Dupixent (dupilumab) for adolescents. Galderma's Restylane Lyft is approved for use with a small, blunt-tip cannula for cheek augmentation and the correction of age-related midface contour deficiencies in patients over the age of 21. TBrightGuard Covers NYC, Galderma Uncovers Rosacea Burden, Dermira's Qbrexza Approved
https://practicaldermatology.com/series/dermwire-tv/dermwire-tv-brightguard-covers-nyc-galderma-uncovers-rosacea-burden-dermira-s-qbrexza-approved/18288/BrightGuard dispensers have now been installed at 53 public pools and 11 beaches in various locations throughout metropolitan New York. The impact of rosacea can be significant for affected patients. According to survey results released last month by Galderma, 86% of patients with rosacea modify the